高低转移卵巢癌细胞株差异表达基因在染色体定位及其功能

用基因芯片技术研究高（H）、低（L）转移卵巢癌细胞株（HO-8910PM和HO-8910）和正常卵巢上皮（C）基因表达谱差异,筛选与卵巢癌转移相关的基因,并利用生物信息学方法对检测结果进行差异基因在染色体定位和功能分析。结果：高、低转移卵巢癌细胞株比较表达差异2倍以上共有409个基因,其中表达上调（信号比的对数值[SLR]≥1）有271个,表达下调（SLR≤-1）有138个。从表达差异的基因在染色体定位分析,发现除1个基因未知其定位外,其余所有差异表达基因散在分布于各条染色体上,但以1号染色体最多有43个（占10．7％）。其次是6号染色体有39个（占9．6％）,第三是2号染色体有29个（占7．1％）。第四是17号染色体有28个（占6．9％）。第五是3号染色体有25个（占6．2％）。第6是5号和11号染色体各有24个（各占5．9％）。而差异表达的基因发生在染色体短臂（q）的有264个（占64．7％）,在13,14,15,21和22号仅发现在q都有异常表达。从表达差异基因的分子功能分类看,属于酶和酶调控子基因为最多（104个,占25．4％）,其次是信号传导基因（43个,占10．5％）。第3类是核酸结合基因（42个,占10．3％）。第4类是蛋白结合基因（34个,占8．3％）。以上4大类共占基因总数54．5％。还有功能未知的基因有76个,占18．6％。高、低转移卵巢癌细胞株差异表达基因散在分布在各条染色体上,但以1、6、2、17、3、5和11号染色体差异表达基因居多。肿瘤的转移是多基因共同作用的结果。4大类（酶和酶调控子、信号传导、核酸结合和蛋白结合）相关基因异常是我们今后研究卵巢癌转移的重要基因。     

卡瑞利珠单抗联合卡培他滨用于一线治疗复发转移鼻咽癌患者维持治疗疗效及对患者免疫功能的影响

摘要 目的：探讨卡瑞利珠单抗联合卡培他滨用于一线治疗复发转移鼻咽癌（NPC）患者维持治疗的疗效及对患者免疫功能的影响。方法：选取2020年1月至2022年1月钦州市第一人民医院收治的80例复发转移NPC患者,按照随机数字表法分为对照组和观察组,每组各40例。两组均接受吉西他滨联合顺铂化疗,对照组化疗后接受卡瑞利珠单抗单药维持治疗至1年,观察组化疗后接受卡瑞利珠单抗联合卡培他滨维持治疗至1年。比较两组疗效,不良反应,治疗前后B淋巴细胞亚群和自然杀伤（NK）细胞所占百分比的差异。结果：观察组客观缓解率（ORR）、疾病控制率（DCR）高于对照组（P＜0.05）。两组治疗后外周血CD5⁺B细胞、CD5⁺CD19⁺ B细胞、CD3^-CD56⁺NK细胞占比降低（P＜0.05）,但观察组治疗后外周血CD5⁺B细胞、CD5⁺CD19⁺ B细胞、CD3^-CD56⁺NK细胞占比高于对照组（P＜0.05）。两组Ⅲ度以上不良反应发生率比较差异无统计学意义（P＞0.05）。结论：卡瑞利珠单抗联合卡培他滨一线维持治疗复发转移NPC可提高临床疗效,减轻对细胞免疫功能的影响,且安全可靠。     

Simplified protocol for clinical-grade tumor-infiltrating lymphocyte manufacturing with use of the Wave bioreactor

Background aimsThe high level of complexity of current Good Manufacturing Practice–compliant methods of manufacturing hampers rapid and broad application of treatment with tumor-infiltrating lymphocytes (TILs).MethodsTo ensure higher applicability of TIL production to laboratory routine, a practical and simple protocol of TIL manufacturing with the use of a closed-system bioreactor was developed and implemented at our institution.ResultsThis protocol enabled significant work load reduction during the most labor-intense step of TIL expansion, and allowed generation of high-quality TIL products, which mediated clinical regression in patients with metastatic melanoma.ConclusionsImplementation of simplified methods of TIL expansion will speed up dissemination of TIL methods worldwide and will increase patient access to this highly effective treatment.     

Metabolic diversity within breast cancer brain-tropic cells determines metastatic fitness

1. Download : Download high-res image (166KB)
2. Download : Download full-size image

     

Intrinsic properties of Boolean dynamics in complex networks

We study intrinsic properties of attractor in Boolean dynamics of complex networks with scale-free topology, comparing with those of the so-called Kauffman's random Boolean networks. We numerically study both frozen and relevant nodes in each attractor in the dynamics of relatively small networks (20?N?200). We investigate numerically robustness of an attractor to a perturbation. An attractor with cycle length of ?_c in a network of size N consists of ?_c states in the state space of 2^N states; each attractor has the arrangement of N nodes, where the cycle of attractor sweeps ?_c states. We define a perturbation as a flip of the state on a single node in the attractor state at a given time step. We show that the rate between unfrozen and relevant nodes in the dynamics of a complex network with scale-free topology is larger than that in Kauffman's random Boolean network model. Furthermore, we find that in a complex scale-free network with fluctuation of the in-degree number, attractors are more sensitive to a state flip for a highly connected node (i.e. input-hub node) than to that for a less connected node. By some numerical examples, we show that the number of relevant nodes increases, when an input-hub node is coincident with and/or connected with an output-hub node (i.e. a node with large output-degree) one another.     

A Novel Scoring System for the Risk of Papillary Thyroid Cancer Metastases in Lymph Nodes Posterior to the Right of the Recurrent Laryngeal Nerve

ObjectiveSome surgeons believe that dissection posterior to the right recurrent laryngeal nerve lymph node (PRRLN-LN) is unnecessary for the low metastasis rate and high complication risk. However, persistent metastatic lymph nodes may have a higher recurrence rate, surgical risk, and complications. Thus, it is important to distinguish patients who require PRRLN-LN dissection. To identify the risk factors for lymph nodes posterior to the right recurrent laryngeal nerve metastasis (LN-prRLN) and establish a scoring system to help determine whether PRRLN-LN dissection is required in patients with papillary thyroid carcinoma.Methods821 participants were randomly allocated to the development and validation cohorts in a 2:1 ratio. A nomogram-based predictive model for LN-prRLN was established based on the risk factors identified in the development cohort.ResultsLN-prRLN was diagnosed pathologically in 124 of 821 patients (15.1%) from the entire cohort. Multivariate analysis identified age (odds ratio [OR], 0.964; 95% CI, 0.945-0.983; P < .001), tumor size (OR, 1.536; 95% CI, 1.135-2.079; P = .005), extrathyroidal extension (OR 2.271, 95% CI, 1.368-3.770; P = .002), clinically involved right central compartment lymph node metastasis (OR 1.643, 95% CI, 1.055-2.559; P = .028), and right lateral lymph node metastasis (OR 4.271, 95% CI, 2.325-7.844; P < .001) as the predictors of LN-prRLN. A risk model was established and well validated. Calibration curves to evaluate the nomogram in both the development and validation cohorts revealed a concordance index of 0.756 ± 0.058 and 0.745 ± 0.042, respectively.ConclusionOur scoring system may be useful for helping the surgeons decide which patients should undergo the dissection of PRRLN-LN.     

Chambered cuticle,pellicles, strange sensilla,and extraordinary muscle arrangements: A study of the micropterigid larval trunk (Lepidoptera: Micropterigidae)

The larvsal trunk wall of Sabatinca chalcophanes (Meyrick, 1885), representing the “sabatincoid morphotype,” is described (brightfield and polarization microscopies, scanning and transmission electron microscopies). Eight sensillum types are identified, including four previously undescribed subventral and ventral kinds. The cuticle is nonsolid, the exocuticle being chambered in a honeycomb‐like fashion with chamber walls apparently secreted along epidermal cells boundaries. The chamber contents open to the exterior via minute pores in the chamber roofs. A space between endo and exocuticle communicates with the chamber interiors via pores in the chamber floors; the dense endocuticular surface in places form thickened domes. On the lower trunk region, lateral chamber walls are highly porous (lattice like), hence their contents are continuous; individual chamber roofs here are markedly convex, and the external trunk surface, therefore, papillate. The trunk surface is more or less completely covered by a pellicle, likely formed by exudates from the exocuticular chambers. Unusually for Lepidoptera all trunk muscles are slender strands covering a modest proportion of the inner trunk surface. Conspicuous insertion “nodes” are located at lateral and ventral segmental boundaries, ventromedially near segmental midlengths, and paramedially on the dorsum behind segmental midlengths. Overall similar cuticular specializations are also present in the distantly related Micropterix, strongly supporting micropterigid monophyly. J. Morphol. 275:797–821, 2014. © 2014 Wiley Periodicals, Inc.     

Differences in Clinical Manifestations and Tumor Features Between Metastatic Pheochromocytoma/Paraganglioma Patients With and Without Germline SDHB Mutation

ObjectiveTo compare metastatic pheochromocytoma/paraganglioma (MPP) patients with germline SDHB mutations (SDHB MPP) and without SDHB mutations (non-SDHB MPP) in terms of baseline clinical manifestations, tumor characteristics, and outcomes.MethodsClinical data were retrospectively reviewed in 101 MPP patients, including 34 SDHB MPP patients and 61 non-SDHB MPP patients.ResultsSDHB MPP patients presented at a younger age at onset, diagnosis, or metastasis (25 ± 16 vs 36 ± 14, 28 ± 17 vs 38 ± 15, and 31 ± 17 vs 44 ± 14 years old, respectively, P < .01 for all) than non-SDHB patients. Compared with their non-SDHB counterparts, SDHB patients were more likely to have paragangliomas (83% vs 47%, P < .05), synchronous metastases (44% vs 23%, P < .05), bone metastases (80% vs 48%, P < .01), and a shorter progression-free survival (3 years vs 5 years, P < .01). The Ki-67 index was higher in SDHB tumors (P < .05). The 5- and 10-year survival rates were 79% and 74%, respectively, in all patients. Seventeen patients died from MPP, and the time from metastasis to death in patients who had received systemic therapy was significantly longer than in those who had not (3.1 ± 1.5 vs 1.4 ± 0.7 years, P < .01).ConclusionCompared with MPP patients without SDHB mutations, MPP patients with SDHB mutations were younger at onset, diagnosis, or metastasis; had a higher incidence of synchronous metastases, higher ratio of paraganglioma, and higher Ki-67 index; had a shorter postoperative progression-free survival; and were more likely to develop bone metastasis or sole liver metastasis. Our results suggest that patients with SDHB mutations should be identified early and monitored regularly to achieve optimal clinical outcomes.     

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

High-grade serous ovarian cancer (HGSC), the cause of widespread peritoneal metastases, continues to have an extremely poor prognosis; fewer than 30% of women are alive 5 years after diagnosis. The omentum is a preferred site of HGSC metastasis formation. Despite the clinical importance of this microenvironment, the contribution of omental adipose tissue to ovarian cancer progression remains understudied. Omental adipose is unusual in that it contains structures known as milky spots, which are comprised of B, T, and NK cells, macrophages, and progenitor cells surrounding dense nests of vasculature. Milky spots play a key role in the physiologic functions of the omentum, which are required for peritoneal homeostasis. We have shown that milky spots also promote ovarian cancer metastatic colonization of peritoneal adipose, a key step in the development of peritoneal metastases. Here we describe the approaches we developed to evaluate and quantify milky spots in peritoneal adipose and study their functional contribution to ovarian cancer cell metastatic colonization of omental tissues both in vivo and ex vivo. These approaches are generalizable to additional mouse models and cell lines, thus enabling the study of ovarian cancer metastasis formation from initial localization of cells to milky spot structures to the development of widespread peritoneal metastases.     

Clinical radioimmunolocalization with a rat monoclonal antibody directed against c-erbB-2

Lymph node status is still the single most important prognostic factor in breast cancer and surgery remains the only reliable means of providing this information. This study evaluates using a highly specific radiolabeled monoclonal antibody to provide equivalent information. The optimum labeling conditions for radiolabeling a monoclonal antibody against the gene product of the protooncogene c-erbB-2 with Tc99m were established. This immunoconjugate was next evaluated in a mouse model system and averaged 20% localization of the total injected dose per gram of tumor at 24h. Ten patients have had this immunoconjugate, with planar and tomographic reconstructed images being obtained at 24 h. The resulting images were compared to histopathological examination of the surgical specimens. Three patients acted as normal controls, two patients were selected on the basis of inappropriate sampling of adjacent ductal carcinomain situ, three patients demonstrated only moderate antigen expression, and two patients demonstrated excellent tumor localization in both breast primary and regional node metastases. The high specificity of this antibody, ease of labeling, and excellent localization performance with a good antigen target encourage the development of this system as a method of localization and a potential means of antibody-guided therapy.